TTop stories Read More 2025 FDA approvalsJanuary 3, 2026 Drug developers secured approvals for 46 new therapeutic agents from the FDA’s Center for Drug Evaluation and Research…
HHeadlines Read More Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line | BMC Research NotesNovember 12, 2025 Reagents RPMI-1640 medium and fetal bovine serum (FBS) were from Gibco (USA). Sigma-Aldrich (USA) supplied trypan blue, MTT,…
HHeadlines Read More Opening the black box: defining true-negative outcomes in esophageal cancer screening — a population-based study | BMC MedicineNovember 7, 2025 Parent study This prospective cohort study was based on the Endoscopic Screening for Esophageal Cancer in China (ESECC,…
HHeadlines Read More Association between prostatic inflammation and detrusor overactivity in men with benign prostatic hyperplasia and bladder outlet obstruction: a prospective urodynamic and histological studyOctober 29, 2025 Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7:S3–14. PubMed PubMed Central Google Scholar Coyne KS, Sexton…
HHeadlines Read More Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variantSeptember 22, 2025 The two-component intranasal vaccine elicits stronger humoral immunity To investigate the potential enhanced effects of combining the adenovirus…
HHeadlines Read More Targeting MHC-E as a new strategy for vaccines and immunotherapeuticsSeptember 3, 2025 Trowsdale, J. & Knight, J. C. Major histocompatibility complex genomics and human disease. Annu. Rev. Genom. Hum. Genet.…
HHeadlines Read More In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA deliveryAugust 12, 2025 Esrick, E. B. et al. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N. Engl. J.…